TABLE 3.
Significant Spearman correlation coefficients: associations between alexithymia and questionnaire scores in patients with fibromyalgia (FMS), rheumatic diseases (RD) and healthy subjects (HC).
| FMS group | RD group | HC group | |
| n = 48 | n = 41 | n = 38 | |
| DIF | |||
| QUID-S | 0.261 | 0.453∗∗ | 0.445∗∗ |
| QUID-A | 0.111 | 0.466∗∗ | 0.368∗ |
| VAS | 0.163 | 0.480∗∗ | 0.505∗∗∗ |
| HADS-A | 0.387∗∗ | 0.383∗ | 0.493∗∗ |
| HADS-D | 0.264 | 0.151 | 0.411∗ |
| DDF | |||
| QUID-S | 0.211 | 0.296 | 0.239 |
| QUID-A | –0.022 | 0.143 | 0.295 |
| VAS | 0.144 | 0.295 | 0.322∗ |
| HADS-A | 0.076 | 0.055 | 0.243 |
| HADS-D | 0.255 | 0.094 | 0.504∗∗∗ |
| EOT | |||
| QUID-S | 0.275 | –0.147 | 0.358∗ |
| QUID-A | 0.209 | –0.167 | 0.380∗ |
| VAS | 0.134 | 0.195 | 0.281 |
| HADS-A | 0.238 | 0.225 | –0.006 |
| HADS-D | 0.102 | 0.341∗ | 0.248 |
Same abbreviations as Table 2. Bold data indicate correlations that are significant. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.